Search results
Results from the WOW.Com Content Network
Cannabis use disorder ( CUD ), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders ( DSM-5) and ICD-10 as the continued use of cannabis despite clinically significant impairment. [ 2][ 3]
Nystagmus. Nystagmus is a condition of involuntary (or voluntary, in some cases) [1] eye movement. [2] People can be born with it but more commonly acquire it in infancy or later in life. In many cases it may result in reduced or limited vision. [3] In normal eyesight, while the head rotates about an axis, distant visual images are sustained by ...
Horizontal Gaze Nystagmus (HGN) testing is a common practice used by law enforcement in the United States in the identification of persons who are intoxicated or under the influence of a controlled substance. The key difference between recognizing PAN and horizontal gaze nystagmus is the position of the subject's head in relation to the body.
Field sobriety testing. Field sobriety tests ( FSTs ), also referred to as standardized field sobriety tests ( SFSTs ), are a battery of tests used by police officers to determine if a person suspected of impaired driving is intoxicated with alcohol or other drugs. FSTs (and SFSTs) are primarily used in the United States, to meet "probable ...
The maker of Robitussin settled a consumer lawsuit that claimed its "non-drowsy" cough and flu medicine causes drowsiness, agreeing to pay $4.5 million and remove the "non-drowsy" claim from its ...
August 9, 2024 at 5:27 PM. WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a ...
Cannabis drug testing describes various drug test methodologies for the use of cannabis in medicine, sport, and law. Cannabis use is highly detectable and can be detected by urinalysis, hair analysis, as well as saliva tests for days or weeks. Unlike alcohol, for which impairment can be reasonably measured using a breathalyser (and confirmed ...
Fox News Digital reached out to the FDA and to Lykos Therapeutics requesting comment. Original article source: FDA rejects MDMA as psychedelic-based treatment for mental health, PTSD Show comments